Biomarker discovery sheds new light on heart attack risk of arthritis drugs
A class of drug for treating arthritis – all but shelved over fears about side effects – may be given a new lease of life following new research. The new study, led by Imperial College London, sheds new light on the 10-year-old question of how COX-2 inhibitors – a type of non-steroidal anti-inflammatory drug (NSAID) […]
